5 amino 1mq cas 5-Amino-1MQ (5mg) purity peptide ideal for laboratory research and development 5-Amino-1MQ - CAS 42464-96-0 -

This article is for general information only and does not replace personalised medical advice

Pregnancy and nursing are practical contraindications due to lack of safety data

Human deafness dystonia syndrome is a mitochondrial disease

By blocking NNMT, 5-Amino 1MQ disrupts the enzymes role in metabolism and energy homeostasis, presenting a unique opportunity to study these processes in detail

From a theoretical pharmacological standpoint, combining a peptide with putative lipolytic activity (AOD 9604) with a potent triple incretin receptor agonist (retatrutide) could potentially amplify metabolic effects but this is speculative and raises the possibility of compounding adverse effects with no safety data to guide dosing or monitoring